Objective. The purpose of this study was to evaluate the analgesic effect of a prilocaine 1 bupivacaine combination in patients undergoing periprostatic nerve block (PNB) by comparing its effects with those of prilocaine alone.
Introduction
Prostate-specific antigen (PSA) entered into clinical use in the 1980s and created a revolution in the diagnosis, treatment, and monitoring of prostate cancer [1, 2] . However, PSA is not solely responsible for this revolution. Another partner in this success is advances made in prostate biopsy. However, prostate biopsy did not advance as rapidly as PSA. Astraldi described the first finger-guided prostate biopsy in the 1930s [3] . In 1989, Hodge et al. [4] developed a sextant biopsy accompanied by transrectal ultrasonography (TRUSG), and prostate biopsy finally assumed its current form when the European Urology Association (EUA) recommended a 10-core biopsy guided by TRUSG [5] .
The number of prostate biopsies performed has increased across the world, and it has become one of the most common same-day procedures performed by urologists. Despite being an outpatient procedure, prostate biopsy is uncomfortable, and 65-90% of patients report pain or discomfort [6] . The principal causes of pain are a feeling of discomfort as the ultrasonography probe enters the rectum and perforation of the prostatic capsule and the stroma by the biopsy needle [7, 8] . In addition to evolution in prostate biopsy technique, similar advances have been recorded in the anesthesia methods used during the procedure, and these have now assumed their present-day form. Although no anesthesia has sometimes been used in the management of pain that will occur during the procedure, various methods have been employed, such as intrarectal lubricant agents, periprostatic nerve block (PNB), intraprostatic anesthesia, pelvic nerve blocks, pudendal nerve block, general anesthesia, and combinations thereof [9] [10] [11] [12] [13] [14] [15] [16] . Among all these methods, the EAU recommends PNB guided by TRUSG for effective anesthesia in prostate biopsy [5] .
PNB can permit a painless biopsy procedure for the patient and a comfortable one for the clinician. Prostate biopsy is an outpatient procedure. Unless a very severe complication arises, the patient does not return to the hospital. However, when the effect of the local anesthetic agent ceases, the patient may feel pain and discomfort.
The primary aim in this randomized prospective study was to investigate the anesthetic effect of a long-and shortterm local anesthetic combination during and after the prostate biopsy procedure and the effect of this on patient comfort. Secondary aims were to evaluate at which stage of prostate biopsy patients were most uncomfortable, whether they felt any regret after the biopsy procedure, and how they were affected psychologically.
Methods

Patient Selection and Evaluation
From March 2012 to January 2017, 400 male patients were enrolled in this study. After obtaining ethics committee approval (Scientific Research Review Board of Samsun Training and Research Hospital, number 12.03.2012/72836), all the patients were informed about the study (probe insertion, detailed ultrasonographic examination of the prostate, local anesthetic agent injection, removal of a specimen from the prostate, and probe removal), and written consents were obtained. This study was a prospective single-center, parallelgroup randomized clinical trial with balanced randomization (1:1). Two hundred samples were chosen for enrollment in each arm of the study. Patients were randomly assigned to one of the two groups to receive either prilocaine or a prilocaine þ bupivacaine combination (200 patients in each group). Pain evaluation during and after biopsy was explained to the patients, and this assessment was performed using an 11-point linear visual analog scale (VAS; 0 ¼ no pain, 10 ¼ very severe pain) based on their previous experiences of pain. The VAS procedure was explained in detail to all patients beforehand. Pain was classified as follows: absence of pain, score of 0; mild pain, score of 0.1 to 3; moderate pain, score of 3.1 to 7; and severe pain, score of 7.1 to 10 (16). Immediately after the biopsy, patients were asked which part of the procedure had been most painful and were asked to select options consisting of rectal probe insertion, local anesthetic agent infiltration, collection of prostatic tissue, removal of the probe, or all of these together. One and six hours after the biopsy, patients were asked whether they would have the procedure performed again if necessary.
Inclusion Criteria
• PSA values: 2.5-10 ng/mL • Prostate volume: 25-50 mL • Adult patients younger than age 75 years • 10 core parts taken from the prostate
Exclusion Criteria
• Patients with PSA values above 10 ng/ml or with positivity determined at digital rectal examination were excluded from the study (since alteration in pain perception might occur due to invasion of the periprostatic nerves in the presence of highly probably high grade prostate cancer).
• Patients who did not attend follow-up six hours after biopsy or who could not be contacted by phone were excluded from the study.
• Patients older than age 75 years were excluded (as the neuropathic component of pain increases with age and as these patients might be unable to fully express themselves).
• Patients with a previous history of prostatectomy were excluded (as pain perception would be affected due to inflammation in the prostate or chronicization of fibrosis following prostatectomy).
• Patients with a prostate volume of less than 25 mL or exceeding 50 mL were excluded (as prostate size is closely associated with pain sensation).
• Patients from whom more or fewer than 10 core parts were taken from the prostate were excluded.
• Patients describing preprocedural pain in the pelvic region (chronic pelvic pain, chronic orchialgia, etc.) were excluded.
• Subjects with rectoanal diseases • Alcohol-dependent subjects • Narcotic-dependent subjects • Patients habitually using analgesics Four hundred fifty patients met the study conditions and were willing to take part, but 50 of these were subsequently excluded because they could not be contacted, and the study was completed with 400 patients (Figure 1 ).
Procedure
Oral ciprofloxacin (500 mg) was started three days prior to the biopsy for antibiotic prophylaxis and was maintained after the procedure, being completed in five days. Patients were placed in the left lateral decubitus position with hip flexion. Cooperation was established by informing patients about the procedures as the biopsy was performed. Before probe insertion, patients received 60 mg of lidocaine gel via the rectal route, and a 6-mHz rectal probe (circumference 74 mm) was inserted with the assistance of lubricant gel. Once the probe had been inserted, the prostate was visualized, and prostate volume was measured with the automatic ellipsoid program (height Â width Â length Â 0.52) on the ultrasound machine. Asymmetric or hypoechoic areas were identified. Next, a total 10 cc of local anesthetic agent was infiltrated (Group 1 received 10 mL of 2% prilocaine, and Group 2 received 5 mL of 2% prilocaine þ 5 mL 0.25% bupivacaine), 4 mL into each prostate-seminal vesicle junction and 2 mL into the apex of the prostate using a 7-inch, 22-gauge spinal needle inserted into the sagittal axis ( Figure 2 ). Intravascular injection was prevented by aspirating the injector before the procedure. Seven to 10 minutes after periprostatic injection, 10 core prostate biopsies were taken using a 25-cm, 18-gauge biopsy needle and an automatic biopsy gun (Bard Max-Core, Bard Peripheral Vascular Ins, Tempe, AZ, USA) ( Figure 3 ). Side effects such as rectal bleeding, hematuria, and hypotension were recorded.
Patients were asked to indicate pain levels during probe insertion, during the procedure, and one hour after the procedure on the VAS, which had previously been explained in detail. Pain levels six hours after biopsy procedures performed in the morning were evaluated in the clinic. Patients undergoing biopsy in the afternoon were contacted by telephone, and pain levels were recorded during telephone interviews.
Telephone Interview
Patients were telephoned six hours after biopsy. One hundred sixty patients were interviewed in this way. However, 50 patients (25 in each group) could not be contacted and were excluded from the study. All telephone interviews were conducted by a research fellow based on the VAS scores, and patients were asked whether they would willingly repeat the procedure.
Statistical Analysis
Data analysis was performed using SPSS software Bupivacaine 1 Prilocaine for Prostate Biopsy mean 6 standard deviation (SD), median (min-max), and frequency (%). The Shapiro-Wilk test was used to analyze normal distribution assumptions of the quantitative outcomes. Numerical variables were compared by the independent samples t test. Ordinal variables were compared by the Mann-Whitney U test. Categorical variables were compared by chi-square or Fisher's exact tests as appropriate. All analyses were planned as intention to treat. A P value of less than 0.05 was considered statistically significant.
Results
No statistically significant differences were observed between the groups in terms of age, body mass index (BMI), PSA values, prostate volume, duration of procedure, or education level (P > 0.05) ( Table 1) . Mean VAS pain scores in different steps of the procedure are shown in Table 2 .
All patients found the prostate biopsy procedure painful. Moderate pain (3.1 to 7) was reported by eight (4%) and 10 (5%) individuals, respectively.
VAS values in the two groups one hour following the procedure were 1.11 6 0.4 and 0.85 6 0.5 cm, respectively (P ¼ 0.001). Twenty-nine (14.5%) and 47 (23.5%) patients in the two groups, respectively, reported feeling no pain (P ¼ 0.08). Two patients in Group 1 felt moderate pain (3.1 to 7) one hour after the procedure, but none in Group 2 felt postprocedure pain.
Pain scores in the groups six hours following the procedure were 0.89 6 0.6 and 0.66 6 0.5 cm, respectively (P ¼ 0.001).
In Groups 1 and 2, 45 (22.5%) and 74 (37%) patients, respectively, reported feeling no pain. Only one patient (0.05%), from Group 1, described moderate pain (3.1 to 7).
Patients' thoughts on biopsy steps and rebiopsy considerations are summarized in Table 3 . No statistically significant difference between subjects responding negatively was determined at one hour, but a significant difference was observed at six hours.
Histopathological examination of biopsy materials revealed prostate cancer in 60 (15%) patients. Thirtyone of these patients were in Group 1 and 29 in Group 2.
Complications
Because this study involved a selective patient group, our complication levels were low, and it will not be possible to compare our findings directly with those of previous studies. Our general complication rates were 9% in Group 1 and 9.5% in Group 2 (P ¼ 0.12). Mild hematuria developed in six patients in Group 1 and four in Group 2, and mild rectal bleeding in five and seven patients, respectively. All these complications were selflimiting, and no interventions were required. Ureteral catheter was applied due to acute urine retention after six hours in three cases in Group 1 and two cases in Group 2. Acute prostatitis developed in four patients in Group 1 and five patients in Group 2. Seven of these were nonspecific infection, whereas Escherichia coli was reported in urine culture from two patients. These patients were hospitalized and received appropriate antibiotic therapy.
Discussion
This 400-case, randomized controlled study revealed that a prilocaine þ bupivacaine combination was as effective as prilocaine alone during the procedure; however, it was superior to prilocaine at the end of six hours. It also revealed that probe insertion was the most painful stage during prostate biopsy. Although TRUSG-guided PNB is described as the gold standard for prostate biopsy, this method is still not satisfactory because 20% of patients are unwilling to undergo a repeat procedure [13] . Different techniques must therefore be developed both in order to reduce postbiopsy pain and provide patients with a more comfortable life. TRUSG-guided prostate biopsies are generally outpatient procedures, and the patient is discharged one hour after the procedure has ended. If patients need not re-present to the physician unless a major problem is experienced, then they can spend the subsequent hours in comfort at home with a prilocaine þ bupivacaine combination.
In their meta-analysis, Li et al. [17] reported that intrarectal local anesthesia did not provide effective pain palliation in prostate biopsy. The use of intrarectal lidocaine gel during TRUSG has become a routine method in many centers. The use of lidocaine gel before the procedure reduces probe-related friction and protects the mucosa. All patients in our study received intrarectal lidocaine gel before the procedure to reduce pain during probe insertion. Because it was applied to patients in both groups, this will not have a great effect on the findings. Nonetheless, probe insertion was the most painful step in TRUSG-guided prostate biopsy in our study. Although all patients routinely received rectal lidocaine gel five minutes prior to probe insertion, all our patients found probe insertion painful. Probe insertion was the most painful step in prostate biopsy according to 122 (61%) patients in Group 1 and 119 (59.5%) patients in Group 2. Probe insertion and geometric probe movements during biopsy cause pain by stimulating the nerve-fiber-rich dentate line through the pressure it places on the anal canal [7] . That pressure on the anal canal is the cause of the pain. Because patients experienced pain during probe insertion despite the use of intrarectal lidocaine, we believe that the use of more flexible rectal probes with smaller diameters can represent an alternative method for reducing pain during probe insertion. Indeed, Fabiani et al. [18] reported that the use of a small-diameter probe significantly reduced pain during insertion.
The most widely performed and recommended method in prostate biopsy is PNB [5] . PNB includes three different techniques: It can be applied to the base or the apex of the prostate, or to both together. All biopsies in our study were performed by a single surgeon. Due to the surgeon's working methods, the site of local anesthesia was both prostate-seminal vesicle junctions and the prostate apex. Applying local anesthesia to both prostate-seminal vesicle junctions is more effective than applying it to the apex of the prostate alone, but combined administration is not superior to application to the prostate-seminal vesicle junction only [17] . Because we applied injection to the base and the apex of the prostate and were satisfied with the results, we recommend injection to both regions.
Like our study, a study by Yılmaz et al. [19] Prostate biopsy is a painful procedure. Approximately 90% of patients experience pain from the procedure, and 5% report unbearable pain [16] . In our study, all patients in both groups experienced pain during the biopsy procedure. Approximately 95% of patients in both groups experienced mild pain (scores of 0.1 to 3). No patient in either group reported severe pain (7.1 to 10). Patients with anorectal pathologies were excluded from our study. This may explain the absence of any patients with severe pain.
In contrast to other studies, we also investigated which stage of prostate biopsy was most painful. The biopsy procedure was divided into five parts: probe insertion, administration of the analgesic agent, removing part of the prostate, removing the probe, and all of these combined. Probe insertion predominated in both groups; 61% of patients in Group 1 and 59.5% in Group 2 reported probe insertion as the most painful stage. Surprisingly, three patients from both groups combined described probe removal as painful. Rectal bleeding developed following probe removal in these three subjects. We believe that the probe halted the bleeding through compression while it was inside the anal canal and the patients experienced pain when bleeding increased following removal of the probe.
Approximately 20% of patients undergoing prostate biopsy wish to have rebiopsies performed under general anesthesia [20] . One in five patients are therefore unhappy with the procedure. Our patients were asked at the end of the first and sixth hours whether they would have the biopsy performed again in the same manner, and the effectiveness of the anesthesia we used was evaluated qualitatively. The percentage of subjects unwilling to have prostate biopsies performed again in the same manner at the end of the first hour was 12.9% in Group 1 and 10.8% in Group 2. At the end of the sixth hour, the percentages were 7% and 2.9%, respectively. Although there was no statistically significant difference between the groups at the end of the first hour, the difference was significant at the end of the sixth hour. Bupivacaine significantly altered patients' opinions on rebiopsies by providing effective analgesia during the hours they were at home.
The patients were routinely re-interviewed after 15 days to assess the pathology results. Thirty-four of the 50 patients who had left the study of their own volition came to this interview. Nineteen of these stated that they had left the study for personal reasons, and 15 of their own volition. When those who left of their own volition were asked the reasons why, they reported experiencing psychological trauma because of the prostate biopsy and being unwilling to speak with anyone. Fifteen (3.5%) of the 434 patients we contacted experienced psychological trauma too severe to permit them to speak to anyone. Prostate biopsy has a negative effect on patients' mental states in terms of the body position and technical issues involved. Clinicians must not forget this effect.
Limitations of the Study
There are certain limitations to this study. Pain is specific to the individual concerned and therefore difficult to measure, and there is no standardized method for doing so. Perceptions of pain may vary on a day-to-day basis. The pain scores are subjective, and it must not be forgotten that patients' pain may vary depending on their mental states.
Strengths of the Study
This study included a large number of enrolled patients, and the standardized surgical procedure was performed by a single experienced surgeon.
Conclusions
Prostate biopsy is an unpleasant experience in terms of the physical position and procedure involved. The duty of clinicians is to provide effective anesthesia in terms of patient comfort and ease. The gold standard for TRUSG-guided prostate biopsy is PPN. A prilocaine þ bupivacaine combination is an effective method from the perspective of the patient and the physician during TRUSG-guided 10-core prostate biopsy procedures. It increases patient comfort by providing perfect analgesia for six hours after the procedure. We believe that the use of a smaller-diameter probe, together with a prilocaine þ bupivacaine combination, will make PNB an almost perfect technique. We recommend a prilocaine þ bupivacaine combination for all clinicians performing TRUSG-guided prostate biopsies.
